PR Newswire Asia's news > Medical/Pharmaceuticals

 < Previous page   |   Title only   |   Print    Next page > 
     
Pulnovo Medical Announces Results of the PADN-HF-PH Trial at ESC Congress 2026, Simultaneously Published in The New England Journal of Medicine (NEJM)
Clinical outcomes from 264 PH-LHD patients demonstrate a 51% reduction in the risk of clinical worsening, a 35.5% decrease in recurrent clinical events, and sustained concurrent improvements in functional ...
2026-09-03T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Tucker Medical selects GE HealthCare MRI technology to advance personalized preventive care in Singapore
Collaboration will explore clinical education, knowledge exchange and imaging excellence across Southeast Asia ...
2026-09-03T    Computer/Electronics   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
ClinHope Officially Establishes Hong Kong Branch to Strengthen Asia-Pacific Market Presence
TAIPEI , Sept. 3, 2026 /PRNewswire/ -- ClinHope today announced the official establishment of its Hong Kong branch. Following its operations in Taiwan and the United States, this marks another step in ...
2026-09-03T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
In Indonesia, stroke care delays accumulate on the way to treatment, new report finds
Indonesian experts call for capability-based referral routing, greater investment in trained stroke teams and broader insurance coverage to close the gap between Western and Eastern Indonesia. ...
2026-09-03T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals   Publishing/Information Service 
Everest Medicines Announces China NMPA Approval of CARDAMYST® for the Conversion of Acute Symptomatic Episodes of Paroxysmal Supraventricular Tachycardia (PSVT) to Sinus Rhythm in Adults
SHANGHAI , Sept. 3, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, ...
2026-09-03T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Insilico Medicine Included in the HKEX Tech 100 Index, Drawing Attention to Opportunities in AI Value Chain
CAMBRIDGE, Mass. , Sept. 3, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage drug discovery company powered by generative artificial intelligence (AI), announced ...
2026-09-03T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
The Galien Foundation Announces the Nominees for the Inaugural 2026 Prix Galien Korea Awards
Historic First Edition Launches in Partnership with MK Media (Maekyung), Yozma Group Korea, the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA), and KoreaBIO at the World Knowledge ...
2026-09-03T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
AAHRPP Accredits Five More Research Entities
21 more organizations earn reaccreditation ...
2026-09-03T    Biotechnology   Health Care/Hospital   Higher Education   Medical/Pharmaceuticals 
Ivonescimab Meets Overall Survival Key Secondary Endpoint in Interim Analysis of Phase III HARMONi-2 Study, Demonstrating Statistically Significant and Clinically Meaningful Benefit Versus Pembrolizumab in First-Line PD-L1-Positive NSCLC
HONG KONG , Sept. 3, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that a pre-specified interim analysis of overall survival (OS) in the HARMONi-2 ...
2026-09-03T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
EpiVax Launches AI-Enhanced Models for Immunogenicity Prediction
PROVIDENCE, R.I. , Sept. 3, 2026 /PRNewswire/ -- EpiVax, Inc. is pleased to announce the release of AI-enabled enhancements to ISPRIâ„¢ , its proprietary in silico platform for assessing the immunogenicity ...
2026-09-02T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2026
Suntek Computer Systems Limited.
All rights reserved